Schedule 6, Block Admission Period to 15 October 2017
This block admission announcement, as required by the AIM Rules, is made every six months and relates to the number of shares that have been issued during this six month period under the Company's approved share option plans.
Name of the company
Craneware plc
Names of the schemes
Approved Share Option Plan 2006; Approved Share Option Plan 2007
Period of return
16/4/2017 to 15/10/2017
Number and class of securities not issued under the scheme at the beginning of the period
263,781 Ordinary Shares @ 1p each
Number of securities issued under the scheme during the period
nil Ordinary Shares @ 1p each
Balance under the scheme of securities not yet issued at the end of the period
263,781 Ordinary Shares @ 1p each
Number and class of securities originally admitted at the date of admission
24,929,950 Ordinary Shares of 1p each on 13 September 2007
Number of shares in issue at the date of this statement
26,961,709 Ordinary Shares of 1p each
Contact name and telephone number
Craig Preston +44 (0) 131 550 3100
Schedule 6, Block Admission Period to 15 April 2017
This block admission announcement, as required by the AIM Rules, is made every six months and relates to the number of shares that have been issued during this six month period under the Company's approved share option plans.
Name of the company
Craneware plc
Names of the schemes
Approved Share Option Plan 2006; Approved Share Option Plan 2007
Period of return
16/10/2016 to 15/4/2017
Number and class of securities not issued under the scheme at the beginning of the period
274,739 Ordinary Shares @ 1p each
Number of securities issued under the scheme during the period
10,958 Ordinary Shares @ 1p each
Balance under the scheme of securities not yet issued at the end of the period
263,781 Ordinary Shares @ 1p each
Number and class of securities originally admitted at the date of admission
24,929,950 Ordinary Shares of 1p each on 13 September 2007
Number of shares in issue at the date of this statement
26,961,709 Ordinary Shares of 1p each
Contact name and telephone number
Craig Preston +44 (0) 131 550 3100
Craneware plc published this content on 18 October 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 18 October 2017 14:05:12 UTC.
Original documenthttps://public.craneware.com/investors/aim-rule-26/announcements/2017/block-listing-interim-review-18-10-2017/
Public permalinkhttp://www.publicnow.com/view/77F6CD38788FE45525001CC0F5ADBA8A8ECD9334
Craneware plc is a United Kingdom company that is engaged in the development, licensing, and ongoing support of computer software for the United States healthcare industry. Its value cycle insights are delivered through its Trisus platform for revenue integrity and 340B management, as well as margin and operational intelligence. Its applications and team of experts contextualize operational, financial, and clinical data, providing insights that clearly demonstrate realistic revenue integrity and 340B compliance opportunities for its customers. Its solutions include Trisus Pricing Transparency, Trisus Pricing Analyzer, Trisus Chargemaster, Insight Medical Necessity, Trisus Claims Informatics, Trisus Supply, Appeals Services, Trisus Healthcare Intelligence, Trisus Supplies Assistant, Trisus Medication Analytic Solutions, Sentinel, Sentrex, Sentrex 330, Referral Verification System (Sentrex), Referral Verification System (Senturion), Sentry Core, Senturion Professional Service and others.
CRANEWARE PLC 
